Detalhe da pesquisa
1.
Organoid cultures derived from patients with advanced prostate cancer.
Cell
; 159(1): 176-187, 2014 Sep 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-25201530
2.
Author Correction: Tumour lineage shapes BRCA-mediated phenotypes.
Nature
; 577(7789): E1, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31822847
3.
Tumour lineage shapes BRCA-mediated phenotypes.
Nature
; 571(7766): 576-579, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31292550
4.
Clinical Impact of a Rapid Genetic Testing Model for Advanced Prostate Cancer Patients.
J Urol
; 209(5): 918-927, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36974724
5.
Niraparib in patients with metastatic castration-resistant prostate cancer and DNA repair gene defects (GALAHAD): a multicentre, open-label, phase 2 trial.
Lancet Oncol
; 23(3): 362-373, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35131040
6.
Clinical annotations for prostate cancer research: Defining data elements, creating a reproducible analytical pipeline, and assessing data quality.
Prostate
; 82(11): 1107-1116, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35538298
7.
Dermatological Adverse Events in Prostate Cancer Patients Treated with the Androgen Receptor Inhibitor Apalutamide.
J Urol
; 207(5): 1010-1019, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35020444
8.
Evaluation of an Integrated Spectroscopy and Classification Platform for Point-of-Care Core Needle Biopsy Assessment: Performance Characteristics from Ex Vivo Renal Mass Biopsies.
J Vasc Interv Radiol
; 33(11): 1408-1415.e3, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35940363
9.
Genomic correlates of clinical outcome in advanced prostate cancer.
Proc Natl Acad Sci U S A
; 116(23): 11428-11436, 2019 06 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31061129
10.
Phase II trial of SM-88, a cancer metabolism based therapy, in non-metastatic biochemical recurrent prostate cancer.
Invest New Drugs
; 39(2): 499-508, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32924093
11.
Meeting report from the Prostate Cancer Foundation PSMA theranostics state of the science meeting.
Prostate
; 80(15): 1273-1296, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32865839
12.
PTEN Loss with ERG Negative Status is Associated with Lethal Disease after Radical Prostatectomy.
J Urol
; 203(2): 344-350, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31502941
13.
Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer.
N Engl J Med
; 375(5): 443-53, 2016 Aug 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-27433846
14.
Circulating Tumor Cells in Prostate Cancer: From Discovery to Clinical Utility.
Clin Chem
; 65(1): 87-99, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30602476
15.
Pharmacokinetics and Biodistribution of a [89Zr]Zr-DFO-MSTP2109A Anti-STEAP1 Antibody in Metastatic Castration-Resistant Prostate Cancer Patients.
Mol Pharm
; 16(7): 3083-3090, 2019 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31117485
16.
Consensus on molecular imaging and theranostics in prostate cancer.
Lancet Oncol
; 19(12): e696-e708, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30507436
17.
Lessons from the SWITCH trial: changing glucocorticoids in the management of metastatic castration-resistant prostate cancer (mCRPC).
Br J Cancer
; 119(9): 1041-1043, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30344307
18.
A phase II study of the dual mTOR inhibitor MLN0128 in patients with metastatic castration resistant prostate cancer.
Invest New Drugs
; 36(3): 458-467, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29508246
19.
Estimation of tumour regression and growth rates during treatment in patients with advanced prostate cancer: a retrospective analysis.
Lancet Oncol
; 18(1): 143-154, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27979599
20.
Prediction of overall survival for patients with metastatic castration-resistant prostate cancer: development of a prognostic model through a crowdsourced challenge with open clinical trial data.
Lancet Oncol
; 18(1): 132-142, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27864015